CD4+ T cells are essential for immunity against these infections and represent an important but under-exploited target in vaccine development, largely because the diversity of functions they can assume during an infection means that reproducing the array of signals for optimal development of the key lineages and in the appropriate tissue(s) in a vaccine setting is extremely challenging. The gene discussed is CD4; the disease is infection.